No Data
No Data
Why Abbott Laboratories Stock Was a Winner on Wednesday
Abbott Laboratories Approves $7 Billion Share Repurchase Program
Stifel Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $130
Jefferies Maintains Abbott Laboratories(ABT.US) With Hold Rating, Raises Target Price to $125
Cautious Outlook on Abbott Laboratories Amid Mixed Financials and Legal Challenges
Abbott Laboratories: Strong Growth Prospects and Strategic Positioning Drive Buy Rating
No Data
No Data